K Health Revenue, Valuation, Funding & Investors
K Health is valued at $900M as of August 2026.
Last K Health valuation
$900M
Undisclosed stage · Aug 2026
Last K Health funding round
$59M
Undisclosed stage · Aug 2026
K Health revenue
$52M
Undisclosed stage · Jul 2023
Key investors in K Health
Mangrove Capital Partners
Lerer Hippeau
Valor Equity Partners
Comcast Ventures
Max Ventures
BoxGroup
About K Health
K Health is a New York City-based digital primary care provider using AI to deliver personalized health assessments and virtual consultations. The app employs machine learning models trained on 20 billion data points to triage symptoms and match users with physicians for 300 conditions. Available nationwide in the US, it serves millions of members through partnerships with health systems like Kaiser Permanente. Founded in 2016, K Health integrates telehealth with predictive analytics for chronic disease management.
Founded
2016
HQ
New York City, NYWebsite
Status
Privately held
Customer focus
B2C
Revenue model
Subscription
Revenue
$52M (Jul 2023)
Valuation
$900M (Aug 2026)
K Health Valuation
K Health is currently valued at $900M, based on its undisclosed-stage round in August 2026.
K Health's valuation has grown 1.3x from $700M at its Series D in November 2020 to $900M in August 2026, across 5 priced rounds.
K Health valuation by funding round
Revenue multiple| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Aug 2026 | Undisclosed stage | $900M | - |
| Jul 2024 | Undisclosed stage | $900M | - |
| Jul 2023 | Undisclosed stage | $800M | 15.4x |
| Jan 2021 | Series E | $1.4B | - |
| Nov 2020 | Series D | $700M | - |
K Health Revenue
K Health's latest recorded revenue is $52M, as of its undisclosed-stage round in July 2023. At a $800M valuation, that implies a 15.4x revenue multiple.
K Health revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Jul 2023 | $52M | $800M | 15.4x | Undisclosed stage |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
K Health Funding History
K Health has raised a total of $439M across 11 funding rounds.
K Health's first fundraising round was a $3M seed round in November 2016. The most recent completed round was a $59M undisclosed-stage round in August 2026.
K Health funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Aug 2026 | Undisclosed stage | - | $59M | $900M | K Health raised $50 million in an equity funding round led by Claure Group, with participation from Pablo Legorreta, founder and CEO of Royalty Pharma, alongside existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management. The round valued the company at about $900 million and was described as oversubscribed. The financing was intended to support expansion of K Health’s AI-powered medical services and growth of its digital primary-care platform. K Health, founded in 2016 and launched in the U.S. in 2018, uses an AI chatbot to triage patients before they speak with primary-care physicians. The company had raised about $380 million to date according to a company co-founder at the time of the round, and it operated in digital primary care and telehealth with a focus on medical intelligence and access to doctors. |
| Jul 2024 | Undisclosed stage | Claure Group (lead); Atreides Management; Pablo Legorreta; Mangrove Capital Partners; Valor Equity Partners | $50M | $900M | K Health is an AI-powered primary care platform that provides personalized virtual care through a chat-based AI co-pilot, integrating electronic medical records to assist doctors with diagnoses, treatments, and comprehensive patient charts, aiming to improve access, quality, and cost-efficiency in primary care. The platform offers 24/7 concierge-like services with assigned providers, accessible via health insurance, and partners with health systems like Cedars-Sinai for longitudinal care programs combining virtual and in-person services. In July 2024, K Health raised approximately $50-88 million in an equity funding round led by Claure Group, with participation from Pablo Legorreta (Royalty Pharma CEO), Mangrove Capital Partners, Valor Equity Partners, and Atreides Management; the round was oversubscribed and valued the company at $900 million post-money. Previously, K Health had raised around $380 million total prior to this round, with earlier rounds including a $132 million Series E in January 2021 at $1.4 billion valuation. Investors highlighted K Health's real-world AI impact in healthcare, addressing physician burnout and fragmented services. The funding will expand clinical AI capabilities, particularly generative AI for personalized primary care, and fuel nationwide growth through additional health system partnerships; K Health operates in 48 states, collaborates with thousands of doctors, UnitedHealthcare, and Elevance Health, and has seen significant growth in its B2B health system business. Over seven years, the company has developed proprietary datasets and AI technology to serve millions, positioning it to reinvent primary care in a post-COVID virtual care landscape. |
| Jul 2023 | Undisclosed stage | Primary Ventures; PICO Venture Partners; Max Ventures; LTS Investments; Cedars Sinai; BoxGroup; Marcy Venture Partners; Mangrove Capital Partners; Valor Equity Partners | $59M | $800M | K Health is an Israeli-founded, data-driven digital primary care platform that uses AI to combine professional medical knowledge with patient clinical data to provide personalized health insights. The company was founded in 2016 by CEO Allon Bloch, Ran Shaul, Israel Roth, and Adam Singolda (CEO of Taboola), and operates from both Israel and the United States. The platform allows users to interact with an AI-powered chatbot that gathers medical information and provides initial diagnostic suggestions, with the ability to connect patients to doctors or nurses if needed. In July 2023, K Health raised $59 million in funding from existing and new investors including Valor Equity Partners, Mangrove Capital Partners, PICO Venture Partners, BoxGroup, Max Ventures, Marcy Venture Partners, Primary Ventures, LTS Investments, and Cedars Sinai (California's largest hospital). Forbes valued the company at $800 million at this round, representing a significant decline from its January 2021 valuation of $1.4 to $1.5 billion when it raised a $132 million Series E. The company's cumulative funding reached $330 million by July 2023. K Health's platform is powered by a unique dataset licensed from Maccabi Healthcare Services in Israel, covering 2.2 million doctor visits over 25 years. As of July 2023, the company reported that 10 million people had interacted with its AI and 3.1 million patients across 48 states had completed a chat with a doctor or nurse visit. The company generated approximately $52 million in revenue in 2022, with roughly 40% coming from direct-to-consumer channels and 60% from enterprise contracts with health systems and providers. Alongside the funding round, K Health announced a strategic partnership with Cedars Sinai to roll out dedicated offerings of its AI-powered primary care services to California patients. The company also published research comparing its AI platform's performance to that of doctors in family medicine, showing 84% agreement with physician diagnoses across 100,000 medical cases. K Health offers primary care, urgent care, pediatric services, and chronic disease treatment including weight loss management, positioning itself as a digital practice partner for hospitals and health systems. |
| Jan 2021 | Series E | Notable Capital (lead); PICO Venture Partners (lead); Valor Equity Partners (lead); LTS Investments | $132M | $1.4B | K Health is an AI-powered telemedicine platform offering a free symptom checker app, text-based virtual primary care consultations, and mental health services at low costs, such as $9 per month subscription or $19 for one-time visits. Founded in 2016 by Israeli entrepreneurs Ran Shaul, Allon Bloch, and Adam Singolda, the New York-based company had raised prior rounds including $48M Series C in February 2020 and $42M Series D in November 2020, bringing total funding before this round to around $132M. On January 19, 2021, K Health closed a $132M Series E funding round at a $1.4 billion valuation, led by GGV Capital and Valor Equity Partners, with participation from Kaiser Permanente pension fund, LTS Ventures, Atreides Ventures, 14W, Max Ventures, PICO Venture Partners, Marcy Venture Partners, Primary Ventures, and Box Group. GGV's Hans Tung and Valor's Antonio Gracias joined the board. This marked the company's third raise in under a year, pushing total funding to over $260M-$273M. The round doubled valuation from November 2020. The funds were earmarked for product expansion, including pediatrics (virtual childcare), integration with electronic health records, and scaling AI-augmented doctor consultations to improve access and affordability. K Health reported over 4 million users, with more than 1 million new users since COVID-19 began, and user base doubling quarterly in 2020 alongside 1,000% revenue growth since the pandemic. Available in all 50 U.S. states, it partnered with Mayo Clinic previously to enhance symptom checker algorithms. Some sources cite slightly varying valuations like $1.5B or 'over $1.4B,' but $1.4B is directly stated for the January 2021 round. |
| Nov 2020 | Series D | Valor Equity Partners (lead); PICO Venture Partners; Max Ventures; Marcy Venture Partners; Atreides Management; 14W | $42M | $700M | K Health is an AI-powered telemedicine and medical intelligence platform founded in 2016 that provides free symptom-checking tools and charges $19 per-session or subscription fees for consultations with online doctors. The company built a robust clinical database using billions of data points to determine treatments and diagnoses for patients with similar symptoms, serving both consumers and partnering with health systems like Mayo Clinic and insurers like Anthem. In November 2020, K Health closed a Series D round of $42 million led by Valor Equity Partners, with participation from 14W, Atreides Management, Marcy Venture Partners, Max Ventures, and PICO Venture Partners, bringing total funding to approximately $140 million at that time. The round enabled K Health to reduce barriers to primary care access; the company had gained over 1 million new users since the start of the COVID-19 pandemic, reflecting strong demand for remote healthcare solutions. As of 2022, K Health reported $52 million in revenue; the company's valuation at its Series D close was not publicly disclosed, though later funding in January 2021 (Series E, $132 million) valued the company at $1.4 billion, and a July 2024 round valued it at $900 million. |
| Feb 2020 | Series C | 14W (lead); Mangrove Capital Partners (lead); Lerer Hippeau; Primary Ventures; Max Ventures; BoxGroup; BlackPine; Comcast Ventures; Elevance Health | $48M | - | K Health is an AI-powered primary care platform offering telemedicine services, enabling personalized clinical care through proprietary AI and data sets, connecting patients with doctors for consultations. The company, founded around 2016 and launched in the U.S. in 2018, operates in 48 states and partners with health systems like Cedars-Sinai, UnitedHealthcare, and Elevance Health. In February 2020, K Health raised $48 million in its Series C funding round, led by 14W and Mangrove Capital Partners, with participation from investors including Comcast Ventures, Lerer Hippeau, and Primary Ventures. The round aimed to expand market reach, improve AI functionalities, and scale the platform. Later traction includes serving about 2,000 patients daily, 10 million AI interactions, and 3.1 million completed doctor or nurse visits as of around 2023. The company has raised over $400 million total across multiple rounds, with subsequent valuations reaching $900 million in 2024 and $1.5 billion in a Series E. Key investors like Mangrove Capital Partners have participated across rounds, supporting AI development and expansion. Later funding, such as a $50 million equity round in July 2024 led by Claure Group valuing the company at $900 million, focused on enhancing generative AI and health system partnerships. |
| Jul 2019 | Series A | Elevance Health | $12M | - | K Health is an AI-driven primary care platform launched in 2018 that uses artificial intelligence and medical chat functions to help physicians optimize diagnosis and treatment. The company serves patients through partnerships with major health systems and insurers, as well as through a direct-to-consumer mobile app. In February 2019, K Health raised $48 million in Series C funding led by insurance giant Anthem, with participation from investors including 14W, Mangrove Capital, Lerer Hippeau, and Primary Ventures. At that time, the company had served more than 2.5 million people and offered physician consultations at up to 90% less than traditional care costs. The company went on to raise significantly larger rounds in subsequent years, including a $142 million Series E in 2021 at a $1.4 billion valuation, followed by a $50 million round in July 2024 at a $900 million valuation, bringing total funding to $380 million. |
| Dec 2018 | Series B | 14W (lead); Comcast Ventures (lead); Mangrove Capital Partners (lead); Lerer Hippeau; Primary Ventures; Max Ventures; BoxGroup; Bessemer Venture Partners | $25M | - | K Health is a New York City-based primary care startup founded in 2016 that developed an AI-driven app using a clinical record database from Israeli managed care organization Maccabi, containing 2 billion health events over 20 years, to provide personalized symptom checking, triage, and health information for conditions like primary care, pediatrics, and orthopedics. The free app, launched earlier in 2018, had grown to over 500,000 users by December 2018, adding 10-15K users daily and briefly topping health & fitness app charts. The company had partnerships with around 40 New York providers and its own physicians to enable connections for in-person or remote care. In December 2018, K Health raised $25 million in a Series B round led by 14W, Comcast Ventures, and Mangrove Capital Partners, with participation from Lerer Hippeau, BoxGroup, Max Ventures, Primary Ventures, Bessemer Venture Partners, bringing total funding to $37.5 million following a $12.5 million Series A earlier that year. The capital was earmarked for platform expansion, marketing, research into early detection, and launching in-app virtual visits in early 2019 at prices below copays, aiming to reduce unnecessary doctor visits and enable better resource allocation in healthcare. K Health differentiates through its rich, real-world dataset for 'people like you' comparisons based on age, gender, history, and symptoms, informing users on condition severity and treatment without replacing physicians. By 2018, it had covered about 200 primary care conditions and planned extensions beyond primary care. Competitors include Buoy Health and Mediktor, but K Health emphasized its superior data foundation and feedback loops from user outcomes to improve AI accuracy. The company reported substantial growth since its prior round, from thousands to nearly half a million downloads, with interest from healthcare value chain partners. |
| Jan 2018 | Series A | Lerer Hippeau; Comcast Ventures; Mangrove Capital Partners; Primary Venture Partners | $6M | - | K Health is a digital primary care platform launched in 2016 that uses artificial intelligence and machine learning to provide affordable healthcare services. The company's AI-powered chat function analyzes patient symptoms, medical history, age, and gender to suggest potential diagnoses and connect patients with healthcare providers when needed. K Health offers primary care, urgent care, pediatric services, and chronic disease treatment through a mobile app interface. In January 2018, K Health closed a Series A funding round of $5.82 million, with investors including Mangrove Capital Partners. The company had not yet disclosed its valuation for this early-stage round. The platform was still in its early growth phase, with the U.S. market launch occurring in 2018, and specific revenue metrics for this period are not publicly available from the sources reviewed. |
| Jun 2017 | Seed | Mangrove Capital Partners (lead) | $3M | - | K Health is an AI-driven primary care platform founded in 2016 that combines medical chat functionality with artificial intelligence predictive models to help physicians optimize diagnosis and treatment. The platform offers concierge-style medical care with an assigned provider and 24/7 access, requiring only health insurance rather than the high out-of-pocket costs typical of traditional concierge medicine services. In June 2017, K Health raised $3.32 million in a seed round led by Mangrove Capital Partners to develop the initial AI-driven primary care platform. The company has since grown significantly, ultimately raising over $400 million in total funding and achieving valuations as high as $1.4 billion in later rounds, with employment reaching around 300 people including 100 based in Israel. |
| Nov 2016 | Seed | Mangrove Capital Partners (lead); Lerer Hippeau; Comcast Ventures; Clover Holdings Ltd; Primary Venture Partners | $3M | - | K Health is an AI-driven primary care platform founded in 2016 that provides personalized healthcare consultations using artificial intelligence and medical data. The company raised approximately $3.3 million in seed funding in November 2016 led by Mangrove Capital Partners, with a prior or follow-on seed of similar size in June 2017 also led by Mangrove. Other investors in later rounds included Comcast Ventures, Lerer Hippeau, and Primary Venture Partners, though specifics for the 2016 round are limited. The early funding supported initial product development, operations kickstart, and building the AI platform for primary care diagnostics and treatment. Mangrove Capital Partners focused on early-stage tech like K Health alongside investments in Skype and Wix. K Health later expanded to Series C in 2020 with $48 million led by 14W and Mangrove, bringing total funding at that time to $97 million. |
Who has invested in K Health?
21 investors have backed K Health across its funding rounds, including Mangrove Capital Partners, Lerer Hippeau, Valor Equity Partners, Comcast Ventures, Max Ventures and BoxGroup.
Lead investors include Claure Group, Notable Capital, PICO Venture Partners, Valor Equity Partners, 14W and 2 other investors.
K Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
 Luxembourg | 7 | Lead | Nov 2016 | |
| New York City, NY | 4 | Participant | Nov 2016 | |
| New York City, NY | 4 | Participant | Dec 2018 | |
| San Francisco, CA | 4 | Lead | Nov 2016 | |
| Chicago, IL | 4 | Lead | Nov 2020 | |
 Buenos Aires | 3 | Participant | Dec 2018 | |
 Jerusalem | 3 | Lead | Nov 2020 | |
| New York City, NY | 3 | Participant | Dec 2018 | |
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} 14W | United States | 3 | Lead | Dec 2018 |
 São Paulo | 2 | Participant | Jan 2021 | |
| San Francisco, CA | 2 | Participant | Nov 2020 | |
| Boston, MA | 2 | Participant | Nov 2020 | |
| United States | 2 | Participant | Jul 2019 | |
This data is available for Pro users. Sign up to see all 21 K Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by K Health
K Health has acquired 1 company to date.
Last acquisition by K Health was on August 24th 2021. K Health acquired Trusst for undisclosed valuation.
Latest Acquisitions by K Health
| Description | Trusst is a teletherapy platform connecting users in India with licensed mental health professionals for confidential video sessions and messaging. Launched in 2021, the Mumbai-based service matches patients by location and specialty, covering anxiety, depression, and relationship counseling with sessions priced from 500 rupees and available in Hindi, English, and regional languages. |
| HQ Country | |
| HQ City | New Hampshire, OH |
| Deal Date | 24 Aug 2021 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all K Health acquisitions and their M&A valuation multiples. Start Free Trial | |
K Health Competitors
K Health competitors include listed companies like JLK and Tempus AI, and private ones like SiBionics, Infinitus Systems, Arbiter and Pearl.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
 China | Private | - | - | $717M | - | |
| San Francisco, CA | Private | - | - | $600M | - | |
| New York City, NY | Private | - | - | $400M | - | |
| Los Angeles, CA | Private | - | - | $400M | - | |
 South Korea | Publicly listed | $2M | ($9M) | $92M | - | |
| United States | Publicly listed | $1.3B | ($131M) | $15B | 10.1x |
K Health Public Comps
K Health is still privately-owned, but its public comps include ODDITY Tech, Talkspace, Beijing Haitian Ruisheng, iFLYHealth, Beijing Deep Glint Tech, Shenzhen Sunwin, Teladoc, Braiin, GoodRx and ZoomInfo.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $810M | $131M | 1.5x | 1.8x | 9.6x | 18.3x | |||
| $229M | $6M | 3.4x | 3.4x | 129.3x | 49.4x | |||
| $56M | $5M | 13.8x | 14.0x | 160.9x | - | |||
| $136M | ($7M) | 7.7x | 6.2x | (150.8x) | (144172.5x) | |||
| $23M | ($29M) | 25.1x | 8.7x | (19.8x) | (80.2x) | |||
| $20M | ($147M) | 37.7x | - | (5.0x) | - | |||
| $2.5B | $124M | 0.6x | 0.6x | 11.3x | 5.0x | |||
| $73M | ($15M) | 15.8x | 13.0x | (76.1x) | 89.6x | |||
This data is available for Pro users. Sign up to see all K Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about K Health
| When was K Health founded? | K Health was founded in 2016. |
| Where is K Health headquartered? | K Health is headquartered in New York City, NY, United States. |
| Is K Health publicly listed? | No, K Health is a private, VC-backed company. |
| What is K Health's valuation? | K Health was last valued at $900M in its undisclosed-stage round in August 2026. |
| How much funding has K Health raised? | K Health has raised $439M across 11 funding rounds. |
| What was K Health's last funding round? | K Health's last funding round was a $59M undisclosed-stage round in August 2026. |
| Who are K Health's investors? | K Health's investors include Mangrove Capital Partners, Lerer Hippeau, Max Ventures, Comcast Ventures, Valor Equity Partners, Primary Ventures, PICO Venture Partners, BoxGroup, 14W, LTS Investments and 11 others. |
| What is K Health's revenue? | K Health's latest recorded revenue is $52M (July 2023). |
| What is K Health's revenue multiple? | K Health's latest valuation implies a 15.4x revenue multiple ($800M valuation on $52M of revenue). |
| Which companies are comparable to K Health? | Companies comparable to K Health include SiBionics, Infinitus Systems, Arbiter, Pearl, JLK and Tempus AI. |
| How many companies has K Health acquired? | K Health has acquired 1 company, including Trusst. |
See companies similar to K Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.